ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 38530 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 38530; 2) Community: the network communities that were significantly associated with the response to NSC 38530; 3) Molecule: the relationships between components within communities and NSC 38530; 4) MDR: the compounds that were significantly associated with the NSC 38530.

NSC Compound Enrichment Correlation
NSC 179074 Lead, bis[(2-cyanoethyl)cyclohexylcarbamodithioato-S,S']-, (T-4)- 0.0267520285931239 0.52355812
NSC 179940 Benzofurazan, 4-(4-methyl-1-piperazinyl)-7-nitro-, 3-oxide 0.0267520285931239 0.34057076
NSC 258812 N,N-Dimethyldaunomycin hydrochloride 0.0267520285931239 0.22389433
NSC 289074 Null 0.0267520285931239 0.8896663
NSC 343499 CI-921: amsacrine derivative 0.0267520285931239 -0.12673242
NSC 366220 Null 0.0267520285931239 0.64995249
NSC 610457 Camptothecin Derivative 0.0267520285931239 -0.011854431
NSC 628560 Null 0.0267520285931239 0.51043786
NSC 628562 4H-1,3,2-Benzodioxastannin-4-one, 7-amino-2,2-diphenyl- 0.0267520285931239 0.50079727
NSC 633512 Null 0.0267520285931239 0.47814765
Total:84  Current:48    [First] [Prev] [Next] [Last]